Loading: 100%
Cotiviti Holdings, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 3,000 (as per Q2 2017)no data available
Sector Application Software, TechnologyApplication Software, Technologyno data available
Ticker COTVno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 173034384246
datesClosing price (adj.)
13.10.201734.78
11.10.201735.10
04.10.201735.33
27.09.201735.28
20.09.201734.71
13.09.201735.48
06.09.201735.70
30.08.201735.23
23.08.201736.00
16.08.201735.82
09.08.201735.97
02.08.201737.28
26.07.201742.85
19.07.201742.11
12.07.201741.17
05.07.201738.10
27.06.201737.90
20.06.201737.23
13.06.201738.14
06.06.201737.35
30.05.201737.68
23.05.201738.72
16.05.201738.94
09.05.201737.64
02.05.201741.57
25.04.201741.71
18.04.201741.40
11.04.201742.45
04.04.201741.37
28.03.201740.36
21.03.201738.87
14.03.201737.18
07.03.201737.67
28.02.201737.48
21.02.201737.04
14.02.201735.68
07.02.201735.02
31.01.201733.86
24.01.201733.46
17.01.201734.53
10.01.201733.67
03.01.201734.65
27.12.201635.17
19.12.201634.25
12.12.201635.29
05.12.201632.80
28.11.201631.45
21.11.201631.61
14.11.201632.96
07.11.201633.07
31.10.201630.87
24.10.201633.30
17.10.201633.35
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
34.78n/a
Market Capitalisation
in million USD
3,206n/a
Enterprise Value
in million USD
0n/a
Common Shares Outstanding
as per Jun 30, 2017
92,168,017n/a
Preferred Shares Outstanding
as per Jun 30, 2017
n/a
Average Basic Shares Outstanding
TTM
90,949,263n/a
Average Diluted Shares Outstanding
TTM
95,900,631n/a
Index Membership
n/a
Business Summary
Cotiviti Holdings Inc supports its client to pay their healthcare claims accurately. It mainly uses its resources and expertise to derive the fair value to pay healthcare claims more accurately between an increasingly complex healthcare environment.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 0n/a
Receivables 0n/a
Total Current Assets 0n/a
PP&E 0n/a
Total Assets 0n/a
Accounts Payable 0n/a
Current Debt 0n/a
Total Current Liabilities 0n/a
Long-Term Debt 0n/a
Total Liabilities 0n/a
Total Equity 0n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value n/a
Other Ratios
Current Ratio 0.0%n/a
Liabilities to Equity Ratio 0.0%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (4 items missing)
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Net revenue
441
541
625
Compensation
165
184
230
Other costs of revenue
15
21
22
Total cost of revenue
179
205
252
Compensation
50
71
97
Other selling, general and administrative expenses
43
66
60
Total selling, general and administrative expenses
93
137
157
Depreciation and amortization of property and equipment
7
13
20
Amortization of intangible assets
52
61
61
Transaction-related expenses
6
1
2
Total operating expenses
411
445
491
Impairment of intangible assets
74
28
0
Operating Income
30
97
134
Interest expense
52
66
49
Loss on extinguishment of debt
22
4
16
Other non-operating (income) expense
0
-1
-1
Total other expense (income)
73
69
64
Income from continuing operations before income taxes
-43
28
70
Income tax expense (benefit)
-17
14
21
Income tax expense (benefit)
-26
13
49
Income from continuing operations
0
1
0
Gain on discontinued operations, net of tax
-26
14
49
Remarks
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (7 items missing)
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
149
111
Restricted cash
n/a
11
9
Accounts receivable, net of allowances
n/a
79
68
Prepaid Expense and Other Assets, Current
n/a
24
15
Accounts receivable, net of allowance for doubtful accounts
n/a
263
202
Deferred Tax Assets, Net, Current
n/a
57
68
Prepaid expenses and other current assets
n/a
1,197
1,196
Property and equipment, net
n/a
594
533
Goodwill
n/a
2
3
Deferred tax assets
n/a
2,114
2,002
Liabilities and owners' equity
Intangible assets, net
n/a
21 21099000
18 18000000
Other long-term assets
n/a
11 10741000
9 9103000
Total assets
n/a
30 29521000
23 23162000
Current maturities of long-term debt
n/a
43 42902000
59 58589000
Customer deposits
n/a
68 67775000
63 62539000
Accounts payable and accrued other expenses
n/a
172 172038000
171 171393000
Accrued compensation costs
n/a
1,013 1012971000
762 762202000
Estimated liability for refunds and appeals
n/a
12 12199000
9 8799000
Total current liabilities
n/a
129 129284000
121 120533000
Long-term debt
n/a
1,154 1154454000
892 891534000
Other long-term liabilities
n/a
1,326 1326492000
1,063 1062927000
Deferred tax liabilities
n/a
807 807419000
912 911582000
Total long-term liabilities
n/a
0 0
0 0
Total liabilities
n/a
-15 -14935000
34 33917000
Commitments and contingencies (Note 6)
n/a
0 77000
0 91000
Common stock
n/a
-5 -4867000
-6 -6156000
Additional paid-in capital
n/a
0 -98000
0 -98000
Commitments and contingencies (Note 8)
n/a
788 787596000
939 939336000
Retained earnings (deficit)
n/a
2,114 2114088000
2,002 2002263000
Remarks restated on n/a restated on Feb 23, 2017 n/a restated on Aug 2, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (11 items missing)
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Net income
-26
14
49
Deferred income taxes
-47
-12
-8
Depreciation and amortization of property and equipment
60
74
81
Stock-based compensation expense
2
3
23
Amortization of debt issuance costs
4
6
4
Accretion of asset retirement obligations
0
0
0
Loss on extinguishment of debt
22
4
16
Loss on impairment of intangible assets
74
28
0
Gain on discontinued operations
0
-1
0
Restricted cash
-6
9
2
Accounts receivable
7
-19
11
Other current assets
-1
-12
8
Other long-term assets
0
0
-1
Customer deposits
6
-9
-2
Accrued compensation
-39
0
16
Accounts payable and accrued other expenses
6
-15
-5
Estimated liability for refunds and appeals
33
-7
-5
Other long-term liabilities
0
0
0
Other
0
-1
-1
Net cash provided by operating activities
96
63
189
Expenditures for property and equipment
-19
-23
-35
Business combinations, net of cash acquired
-1,073
0
0
Other investing activities
0
0
1
Net cash used in investing activities
-1,092
-23
-34
Net proceeds from issuance of common stock
365
0
227
Proceeds from exercise of stock options
0
0
4
Dividends paid
0
0
-150
Proceeds from issuance of debt
1,395
0
800
Payment of debt issuance costs
-50
-1
-7
Purchase of treasury shares
0
0
0
Payment of contingent consideration
-1
0
0
Repayment of debt
-684
-8
-1,067
Net cash provided by (used in) financing activities
1,026
-9
-193
Effect of foreign exchanges on cash and cash equivalents
-1
-1
-1
Net (decrease) increase in cash and cash equivalents
30
31
-39
Remarks
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
restated on Feb 23, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo